Streamline Health Announces Pricing of Upsized $14 Million Public Offering of Common Stock
ATLANTA, GA, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline Health”), provider of the eValuator™...
Staff
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of Chronic Hepatitis B Virus
Trial will evaluate Assembly’s core inhibitor candidate, vebicorvir, with Arbutus’ RNAi therapeutic candidate, AB-729, and standard-of-care NrtI therapy SOUTH SAN...
Golden Leaf Holdings Enters into Letter of Intent to Acquire Retail Chain
PORTLAND, Ore., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf,” “GLH” or...
Crescent European Specialty Lending Announces Refinancing for Leading Contract Research Organization Avania
LONDON & LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, a leading alternative asset management firm, announced today that its European Specialty...
Glaukos Announces Positive Phase 3 Trial Results for iLink™ Epi-on Investigational Therapy That Met the Primary Efficacy Endpoint
Study Met Primary Efficacy Endpoint with Statistically Significant Improvement in Maximum Corneal Curvature at 6 Months Epi-on Treatment Demonstrated the...
Axonics® Reports Fourth Quarter and Fiscal Year 2020 Results
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable...
Glaukos Corporation Announces Fourth Quarter and Full Year 2020 Financial Results
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Axonics® Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid®
Combination creates a global leader for incontinence solutions Acquisition of Bulkamid is expected to be immediately accretive to Axonics IRVINE,...
Hemogenyx Pharmaceuticals PLC Announces Conversion of Convertible Loan Notes
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW...
Aquarius Surgical Technologies Provides Update in Relation to Irregular Activity Uncovered at Surgical Lasers Inc.
TORONTO, ON / ACCESSWIRE / February 25, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or the "Company") announces further...
Texas Medical Technology Partners with My Protect Kit, LLC to Boost PPE Quality and Availability
NBA Champion Byron Scott and two-time NBA All-Star Carlos Boozer have partnered up with Texas Medical Technology and My Protect...
All-New Virtual Event “MD&M | BIOMEDigital” Connects the Global Medtech and Biomedical Device Community
The two-day virtual experience is the medtech industry’s most robust platform that enables networking, education, and deal-making by combining the...
Stella Diagnostics Announces Key Additions to its Board of Directors
SALT LAKE CITY, UT / ACCESSWIRE / February 25, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company")...
How Prevalence of Urinary Disorders is Spurring Growth of Foley Catheter Market: Future Market Insights Report Analyses
The need for foley catheters will reign strong for years to come as the prevalence of urinary diseases continues to...
How to Rise in Peripheral Artery Disease is Spurring Growth of Skin Perfusion Pressure Testing Devices Market: Future Market Insights Report Analyses
Approximately 200 million people aged 40 years and older have PAD. The increasing PAD population has propelled the growth of...
American Kidney Fund Announces 2021 Class of Corporate Members Aligned in Fighting Kidney Disease
ROCKVILLE, MD / ACCESSWIRE / February 25, 2021 / The American Kidney Fund (AKF) today announced the 2021 class of...
NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / February 25, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4
Management to host conference call and webcast at 4:30 pm ET on that day LA JOLLA, Calif, Feb. 25, 2021...
Rénibus Therapeutics to Present Phase 1b Data on RBT-1 at Acute Kidney Injury & Continuous Renal Replacement Therapy 2021 Conference
DALLAS, Texas, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Rénibus Therapeutics, Inc., a clinical-stage biotech company focusing on the prevention, treatment, and...
CohBar to Present at the H.C. Wainwright Global Life Sciences Conference
MENLO PARK, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...